Page last updated: 2024-10-16

carbamates and Nevi, Melanocytic

carbamates has been researched along with Nevi, Melanocytic in 4 studies

Research Excerpts

ExcerptRelevanceReference
"Encorafenib is a BRAF inhibitor increasingly used as a second-line treatment for metastatic melanoma and colorectal cancer."1.72Eruptive naevi associated with encorafenib for metastatic colorectal cancer: two cases. ( Alfallouji, Y; Borysiewicz, C; Bunker, CB; Calonje, E; Hodgkinson, T; Perrett, CM; Sidwell, RU; Spencer, A; Wasan, H; Watchorn, R, 2022)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (25.00)24.3611
2020's3 (75.00)2.80

Authors

AuthorsStudies
Omori, R1
Miyagaki, T1
Miyano, K1
Hashimoto, Y1
Kadono, T1
Alfallouji, Y1
Spencer, A1
Calonje, E1
Perrett, CM1
Watchorn, R1
Borysiewicz, C1
Hodgkinson, T1
Wasan, H1
Bunker, CB1
Sidwell, RU1
Mikami, H1
Akasaka, E1
Nakano, H1
Sawamura, D1
Anforth, RM1
Carlos, GR1
Scolyer, RA1
Chou, S1
Fernandez-PeƱas, P1

Other Studies

4 other studies available for carbamates and Nevi, Melanocytic

ArticleYear
Multiple pigmented nevi induced by the combination of encorafenib and cetuximab in a colon cancer patient.
    The Journal of dermatology, 2022, Volume: 49, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carbamates; Cetuximab; Colonic Neoplasms; Colorectal

2022
Eruptive naevi associated with encorafenib for metastatic colorectal cancer: two cases.
    Clinical and experimental dermatology, 2022, Volume: 47, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carbamates; Colonic Neoplasms; Exanthema; Humans; Mu

2022
Eruptive melanocytic nevi associated with encorafenib and cetuximab combination therapy.
    The Journal of dermatology, 2023, Volume: 50, Issue:5

    Topics: Carbamates; Cetuximab; Humans; Nevus, Pigmented; Skin Neoplasms

2023
Eruptive naevi in a patient treated with LGX818 for BRAF mutant metastatic melanoma.
    Melanoma research, 2015, Volume: 25, Issue:1

    Topics: Antineoplastic Agents; Carbamates; Dermatology; Dermoscopy; Humans; Male; Melanoma; Middle Aged; Mut

2015